UNH Stock Recent News
UNH LATEST HEADLINES
Major U.S. equities indexes were mixed on the final day of an abbreviated trading week, with markets set to remain closed on Good Friday.
I underestimated UnitedHealth's vulnerability to rising medical costs, leading to a significant earnings miss and a 20% drop in market cap. Despite recent setbacks, UnitedHealth's long-term potential remains strong, with expected 13-16% annual earnings growth and attractive entry points for new investors. Rising healthcare costs and inflation pose significant challenges, making UnitedHealth less of a high-conviction pick in the near term.
UNH continues to witness significant growth in medical costs. However, its operating cost ratio improves.
Weak results from UnitedHealth arern't hurting all healthcare stocks. Eli Lilly is soaring on promising weight-loss pill news.
Wall Street saw a rebound in risk appetite on Thursday ahead of the long Easter weekend, as President Donald Trump signaled positive momentum in trade negotiations.
One of the Investment Committee members is doubling down on UnitedHealth—here's what they're seeing.
The major U.S. equities indexes were mixed at midday Thursday, with the Dow Jones Industrial Average down close to 400 points as UnitedHealth Group (UNH) shares plunged. The tech-heavy Nasdaq and the S&P 500 were slightly higher.
United Healthcare has cut its 2025 forecast. Transcript: UNITED HEALTHCARE WAS BACK IN THE HEADLINES AFTER MISSING ANALYST EARNINGS EXPECTATIONS AND CUTTING ITS ANNUAL PROFIT FORECAST.
Healthcare stocks are getting shellacked today, pressured by a double-digit percentage drop in United Healthcare (NYSE: UNH).
The stock market sold off this week, with Nvidia AI chip export curbs, UnitedHealth guidance and Fed chief Jerome Powell's comments in focus.